OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

SCHWAB CHARLES CORP (SCHW-PD) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

SCHW-PD · SCHWAB CHARLES CORP

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 67 filings · fetched 2026-11-13T19:57:43Z

Recent reported activity

0purchase rows on this page
9sale rows on this page
126matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-11-10Filed 2026-11-10Schwab Charles R.Director · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $92.835 to $93.135. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

References:

G GiftCommon Stock · Non-derivative31,850D0Indirectby TrustForm 4 ↗0000923738-26-000052
2026-11-09Filed 2026-11-10Schwab Charles R.Director · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $92.835 to $93.135. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

References: F1

S Sale (market/private)Common Stock · Non-derivative70,750D93.0074Indirectby TrustForm 4 ↗0000923738-26-000052
2026-11-03Filed 2026-11-05Schwab Charles R.Director · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $89.115 to $89.30. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

References: F1

S Sale (market/private)Common Stock · Non-derivative11,675D89.2149Indirectby TrustForm 4 ↗0000923738-26-000050
2026-11-02Filed 2026-11-03Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $88.49 to $89.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F4

M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative5,000D0DirectForm 4 ↗0001879974-26-000017
2026-11-02Filed 2026-11-03Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $88.49 to $89.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F2, F3, F1

S Sale (market/private)Common Stock · Non-derivative5,000D88.9236Indirectby TrustForm 4 ↗0001879974-26-000017
2026-11-02Filed 2026-11-03Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $88.49 to $89.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F1

M Exercise / conversionCommon Stock · Non-derivative5,000A64.1DirectForm 4 ↗0001879974-26-000017
2026-10-29Filed 2026-10-29Schwab Charles R.Director · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $88.185 to $88.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F2 This transaction was executed in multiple trades at prices ranging from $89.06 to $89.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

References: F2

S Sale (market/private)Common Stock · Non-derivative136,400D89.5005Indirectby TrustForm 4 ↗0000923738-26-000048
2026-10-28Filed 2026-10-29Schwab Charles R.Director · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $88.185 to $88.59. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F2 This transaction was executed in multiple trades at prices ranging from $89.06 to $89.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

References: F1

S Sale (market/private)Common Stock · Non-derivative66,750D88.3559Indirectby TrustForm 4 ↗0000923738-26-000048
2026-10-01Filed 2026-10-05Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $97.275 to $98.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F4

M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative5,000D0DirectForm 4 ↗0001879974-26-000015
2026-10-01Filed 2026-10-05Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $97.275 to $98.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F2, F3, F1

S Sale (market/private)Common Stock · Non-derivative5,000D97.8014Indirectby TrustForm 4 ↗0001879974-26-000015
2026-10-01Filed 2026-10-05Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $97.275 to $98.23. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F1

M Exercise / conversionCommon Stock · Non-derivative5,000A41.98DirectForm 4 ↗0001879974-26-000015
2026-10-01Filed 2026-10-05Brown Marianne CatherineDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit ("RSU") represents a right to receive one share of company stock.

F2 The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan.

F3 The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when she leaves the Board of Directors.

F4 The RSUs were received in lieu of cash compensation otherwise payable as director fees.

F5 Includes 23.85 RSUs acquired through dividend reinvestment.

References: F1, F2, F4, F3, F5

A Award / grantRestricted Stock Units · Derivative407A—DirectForm 4 ↗0001804183-26-000016
2026-10-01Filed 2026-10-05Ruffel Charles A.Director
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 The option was received pursuant to the Directors' Compensation Plan II and vested immediately.

F2 The option was received in lieu of cash compensation otherwise payable as director fees.

References: F2, F1

A Award / grantNonqualified Stock Option (right to buy) · Derivative1,222A0DirectForm 4 ↗0001739929-26-000010
2026-10-01Filed 2026-10-05Ellis Stephen ADirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit ("RSU") represents a right to receive one share of company stock.

F2 The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan.

F3 The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors.

F4 The RSUs were received in lieu of cash compensation otherwise payable as director fees.

F5 Includes 38.29 RSUs acquired through dividend reinvestment.

References: F1, F2, F4, F3, F5

A Award / grantRestricted Stock Units · Derivative369A—DirectForm 4 ↗0001561563-26-000025
2026-10-01Filed 2026-10-05HERRINGER FRANK CDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Each restricted stock unit ("RSU") represents a right to receive one share of company stock.

F2 The RSUs were received pursuant to the Directors' Deferred Compensation Plan II (the "Plan") and are held in a rabbi trust for the benefit of the reporting person pursuant to the terms of the Plan.

F3 The RSUs are held in a rabbi trust for the benefit of the reporting person and are distributed to the reporting person when he leaves the Board of Directors.

F4 The RSUs were received in lieu of cash compensation otherwise payable as director fees.

F5 Includes 440.52 RSUs acquired through dividend reinvestment.

References: F1, F2, F4, F3, F5

A Award / grantRestricted Stock Units · Derivative445A—DirectForm 4 ↗0001171694-26-000012
2026-09-23Filed 2026-09-25Ellis Stephen ADirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of shares received upon exercise of the option to a trust.

F2 Includes 299.7567 shares acquired through dividend reinvestment.

F3 The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately.

References: F3

M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative1,918D0DirectForm 4 ↗0001561563-26-000023
2026-09-23Filed 2026-09-25Ellis Stephen ADirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of shares received upon exercise of the option to a trust.

F2 Includes 299.7567 shares acquired through dividend reinvestment.

F3 The option was received pursuant to the Directors' Deferred Compensation Plan II and vested immediately.

References: F1

M Exercise / conversionCommon Stock · Non-derivative1,918A31.48DirectForm 4 ↗0001561563-26-000023
2026-09-01Filed 2026-09-02Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $108.51 to $109.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F4

M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative3,177D0DirectForm 4 ↗0001879974-26-000013
2026-09-01Filed 2026-09-02Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $108.51 to $109.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F2, F3, F1

S Sale (market/private)Common Stock · Non-derivative3,177D109.0425Indirectby TrustForm 4 ↗0001879974-26-000013
2026-09-01Filed 2026-09-02Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $108.51 to $109.50. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F1

M Exercise / conversionCommon Stock · Non-derivative3,177A52.05DirectForm 4 ↗0001879974-26-000013
2026-08-28Filed 2026-08-31Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $107.805 to $108.725. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F4

M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative3,177D0DirectForm 4 ↗0001879974-26-000010
2026-08-28Filed 2026-08-31Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $107.805 to $108.725. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F2, F3, F1

S Sale (market/private)Common Stock · Non-derivative3,177D108.1201Indirectby TrustForm 4 ↗0001879974-26-000010
2026-08-28Filed 2026-08-31Hathi NeeshaOfficer · MD, Head Wealth Adv, Bnk, Tst
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Reflects the contribution of the shares received upon exercise of the option to a trust.

F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on May 29, 2026.

F3 This transaction was executed in multiple trades at prices ranging from $107.805 to $108.725. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F1

M Exercise / conversionCommon Stock · Non-derivative3,177A52.05DirectForm 4 ↗0001879974-26-000010
2026-08-28Filed 2026-08-31Bettinger Walter WDirector · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $110.90 to $110.98. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F2 Includes 7.0627 shares acquired through dividend reinvestment.

F3 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F3

M Exercise / conversionNonqualified Stock Option (right to buy) · Derivative74,388D0DirectForm 4 ↗0001296479-26-000014
2026-08-28Filed 2026-08-31Bettinger Walter WDirector · Officer · Co-Chairman
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 This transaction was executed in multiple trades at prices ranging from $110.90 to $110.98. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F2 Includes 7.0627 shares acquired through dividend reinvestment.

F3 The option was granted under the company's 2013 Stock Incentive Plan and vested in four equal annual installments beginning on the first anniversary of the grant date.

References: F1

S Sale (market/private)Common Stock · Non-derivative74,388D110.9137Indirectby Family TrustForm 4 ↗0001296479-26-000014

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.